- Home
- MD
as 07-26-2024 4:00pm EST
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment and generates majority of the revenue through neonatology and other pediatric subspecialties.
| Founded: | 1979 | Country: | United States |
| Employees: | N/A | City: | SUNRISE |
| Market Cap: | 646.3M | IPO Year: | 1995 |
| Target Price: | $8.70 | AVG Volume (30 days): | 784.0K |
| Analyst Decision: | Hold | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.85 | EPS Growth: | N/A |
| 52 Week Low/High: | $6.62 - $15.02 | Next Earning Date: | 08-06-2024 |
| Revenue: | $1,998,733,000 | Revenue Growth: | 0.91% |
| Revenue Growth (this year): | 4.13% | Revenue Growth (next year): | 2.26% |
Stock Insider Trading Activity of Pediatrix Medical Group Inc. (MD)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Swift James D | MD | Chief Executive Officer | Dec 14 '23 | Sell | $9.58 | 5,764 | $55,219.12 | 90,874 | SEC Form 4 |
| Moore Mary Ann E | MD | EVP, General Counsel & Sec | Dec 14 '23 | Sell | $9.62 | 1,150 | $11,063.00 | 15,730 | SEC Form 4 |
| Moore Mary Ann E | MD | EVP, General Counsel & Sec | Dec 14 '23 | Sell | $9.62 | 970 | $9,331.40 | 81,385 | SEC Form 4 |
Latest Pediatrix Medical Group Inc. News
MD Breaking Stock News: Dive into MD Ticker-Specific Updates for Smart Investing
Zacks
2 days ago
Implied Volatility Surging for Pediatrix Medical (MD) Stock Options
Argus Research
3 days ago
MD: What does Argus have to say about MD?
Business Wire
9 days ago
Pediatrix Medical Group 2024 Second Quarter Conference Call/Webcast Scheduled for Tuesday, August 6, 2024
Argus Research
10 days ago
MD: Raising target price to $8.00
Argus Research
17 days ago
MD: What does Argus have to say about MD?
Zacks
2 months ago
Implied Volatility Surging for Pediatrix Medical (MD) Stock Options
Business Wire
2 months ago
Pediatrix Medical Group To Present at Upcoming Investor Conferences
Simply Wall St.
2 months ago
Returns At Pediatrix Medical Group (NYSE:MD) Appear To Be Weighed Down
Compare MD vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MD Pediatrix Medical Group Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.